AQSTAquestive Therapeutics, Inc.

Healthcare

$4.77-20% 1Y

$4.77

$2.9552 weeks$7.49

Is it growing?

Good

Growing: revenue growing +23% year on year and operating margin widening (+27.9 points).

2 good, 1 without data

Revenue trend+23% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +5% a year.

Margin direction+27.9 points operating

Trailing-twelve-month operating margin, -100.0% now against -127.8% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is AQST growing?

Aquestive Therapeutics, Inc. has grown revenue 5.1% a year over three years and 5.3% a year over five.

+5.1%

Revenue growth, 3-year annual rate · Drug Manufacturers - Specialty & Generic median +13% · steady growth, ahead of inflation · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +5.3%
Revenue growth, 5-year rate · +5.1% over three · growth has slowed since the five-year average
Years of annual history on file: 9
Years of annual history on file · FY2017 to FY2025, as filed

Details›